Cradle is a biotechnology platform that helps biologists design improved proteins in record time by using powerful prediction algorithms and AI design suggestions. The platform, developed by Cradle Bio B.V., streamlines the protein design process, saving time, and increasing the accuracy of predictions [1, 2]. Cradle aims to revolutionize various industries by enabling cells to produce almost anything, from fabrics to food, fuel, and more.
In November 2022, this tool exited stealth mode and announced that it had raised €5.5 million in seed funding, co-led by Index Ventures and Kindred Capital [3]. The platform provides software that helps users find, understand, and improve proteins. However, it is important to note that the services are still under development and are currently provided on an “as is” basis.
This tool prioritizes privacy and security, ensuring that users maintain complete ownership of their intellectual property, as well as the privacy and security of their sequences and data. Additionally, the company has collaborated with Bits in Bio to create the Bio Developer Survey, which aims to develop better software for synthetic biology and advance the field of biotech.
For more information, visit their website at https://cradle.bio.
